John D. Morberg's most recent trade in Lifecore Biomedical Inc was a trade of 17,500 Restricted Stock Unit done . Disclosure was reported to the exchange on Jan. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Morberg D. John | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 17,500 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Morberg John D. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 17,500 | 131,900 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | John Morberg D. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 18 Jan 2024 | 6,283 | 125,617 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 50,000 | 114,400 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 45,000 | 64,400 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 13,500 | 13,500 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 12,591 | 13,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 409 | 409 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 40,229 | 40,229 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 9,771 | 9,771 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 5,123 | 5,123 | - | - | Restricted Stock Unit |